Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia SARS Antigen point-of-care test.

Stephen Young; Stephanie Taylor; Catherine Cammarata; Celine Roger-Dalbert; Amanda Montano; Christen Griego-Fullbright; Cameron Burgard; Catherine Fernandez; Karen Eckert; Jeffrey C Andrews; Huimiao Ren; Joseph Allen; Ronald Ackerman; Devin Gary; Charles Cooper.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20185777

Documentos relacionados

  1. Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
  2. Rapid antigen detection test for respiratory syncytial virus diagnosis as a diagnostic tool
  3. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.
  4. SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
  5. Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
  6. Comparison of the Quidel Sofia SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients.
  7. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
  8. Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy.
  9. Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting.